Browsing by author "AHern, Roger"
Now showing items 1-6 of 6
-
Assessment of the contribution of the IHC4+C score to decision making in clinical practice in early breast cancer.
(2012-05)Background The immunohistochemical (IHC) 4+C score is a cost-effective prognostic tool that uses clinicopathologic factors and four standard IHC assays: oestrogen receptor (ER), PR, HER2 and Ki67. We assessed its utility ... -
Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast.
(2014-04)Micropapillary carcinoma (MPC) is a rare histological special type of breast cancer, characterized by an aggressive clinical behaviour and a pattern of copy number aberrations (CNAs) distinct from that of grade- and oestrogen ... -
Proliferation and apoptosis as markers of benefit in neoadjuvant endocrine therapy of breast cancer.
(2006-02)The study of changes in proliferation as a marker of treatment benefit during presurgical endocrine treatment of breast cancer has become increasingly popular, particularly using the nuclear marker Ki67, and holds the ... -
Short-term presurgical treatment for all?
(BIOMED CENTRAL LTD, 2007-01-01) -
Test of association between variant tgβ1 alleles and late adverse effects of breast radiotherapy.
(2010-10)Purpose To test for association between single nucleotide polymorphisms at the TGFβ1 locus and the risk of late normal tissue injury following whole breast radiotherapy.Methods A retrospective study compared the number of ...
